-- Anheuser-Busch, Commerzbank, Novartis: Europe Equity Preview
-- B y   E l i z a b e t h   S t a n t o n
-- 2010-10-01T04:01:00Z
-- http://www.bloomberg.com/news/2010-09-30/anheuser-busch-commerzbank-gdf-suez-novartis-european-equity-preview.html
Shares of the following companies may
have unusual moves in  European  trading. Stock symbols are in
parentheses.  The  Stoxx Europe 600 Index  fell 0.5 percent to 259.72. The
 Stoxx 50 Index  declined 0.6 percent to 2,482.18. The  Euro Stoxx
50 Index , a benchmark for nations using the euro, slipped 0.2
percent to 2,747.90.  Anheuser-Busch InBev NV  (ABI BB): AB InBev board member
Gregoire de Spoelberch sold 100,000 shares of the world’s
largest brewer for 4.3 million euros ($5.86 million) in
transactions on Sept. 24, a regulatory filing showed. AB InBev
dropped 1 percent to 43.15 euros.  Commerzbank AG  (CBK GR): Germany’s second-biggest bank may
sell shares in a capital increase this year, Frankfurter
Allgemeine Zeitung reported. The Frankfurt-based lender’s
supervisory board will meet in October to discuss a possible
sale, the newspaper said, without saying where it obtained the
information. The shares rose 2 percent to 6.13 euros.  Dexia SA  (DEXB BB): The largest lender to local governments
in France and Belgium agreed to establish a commercial-banking
partnership with Credit Mutuel-CIC in France, giving Dexia
Credit Local’s clients access to services from Credit Mutuel-
CIC. Dexia gained 2.6 percent to 3.23 euros.  France Telecom SA  (FTE FP): The telecommunications company
said it bought 70 percent of submarine cable operator Elettra
from Telecom Italia SpA. The transaction was based on an
enterprise value for Elettra of 20 million euros, France Telecom
said. The shares declined 1.2 percent to 15.85 euros.  GDF Suez SA  (GSZ FP): The energy company said it bought
Societe Generale SA’s 49 percent holding in energy trader
Gaselys, increasing its own stake to 100 percent. GDF Suez
Chairman Jean-Francois Cirelli will also be chairman of the
Gaselys board. The shares fell 0.2 percent to 26.26 euros.  Novartis AG  (NOVN VX): A U.S. unit of the Swiss drugmaker
agreed to pay $422.5 million to resolve criminal and civil
investigations into the marketing of its epilepsy drug
Trileptal. The shares fell 0.3 percent to 56.35 Swiss francs.  To contact the reporter on this story:
Elizabeth Stanton in New York at 
 estanton@bloomberg.net   To contact the editor responsible for this story:
David Merritt at   dmerritt1@bloomberg.net . 